Kodiak Sciences Inc at Citi BioPharma Conference (Virtual) Transcript
All right. I believe we're live now. So I just want to say, thanks, everybody, for taking the time to join the Citi 15th Annual Biopharma Conference. My name is Neena Bitritto-Garg. I'm one of the smid-cap biotech analyst here at Citi. And I'm very pleased to be joined for our next fireside chat by the management team for Kodiak Sciences.
So just to start off, Victor, if you want to make some opening remarks just about Kodiak and the exciting things that you guys are doing, that would be great.
Thanks, Neena. Well, we're pleased to be invited to the conference. Thanks for having us. It's an exciting time at Kodiak here. Our ABC platform and our lead molecule, KSI-301, really making a tremendous amount of progress.
As you may remember, we're a company that was founded back in 2009. And so we're really in our 10-plus years of design and development of the platform, our lead
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |